US Black Cisgender Women and Pre-exposure Prophylaxis for Human Immunodeficiency Virus Prevention: A Scoping Review

Overview

Journal Womens Health (Lond)

Specialty Gynecology & Obstetrics

Date 2022 Jun 14

PMID 35699104

Authors

Cherie Conley

Ragan Johnson

Keosha Bond

Sullivan Brem

Jasmine Salas

Schenita Randolph

Affiliations

Soon will be listed here.

Abstract

Background: Black cisgender women in the United States experience a disproportionate burden of human immunodeficiency virus acquisition. Pre-exposure prophylaxis is an effective oral daily medication that reduces the risk of human immunodeficiency virus through sex by 99% when taken as prescribed. However, less than 2% of eligible Black cisgender women take pre-exposure prophylaxis. The purpose of this scoping review was to describe the types of research studies done in this area, gaps in knowledge, and potential areas of research needed to increase pre-exposure prophylaxis use among Black cisgender women in the United States.

Methods: We conducted our search in MEDLINE (PubMed), Embase (Elsevier), CINAHL (EBSCOhost), PsycINFO (EBSCOhost), and Scopus (Elsevier) using a combination of keywords and database-specific subject headings for the following concepts: pre-exposure prophylaxis, African American/Black or minority, and women. We used the Joanna Briggs Institute's Reviewers' Manual process for Scoping Reviews and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews to ensure comprehensive and standardized reporting of each part of the review.

Results: Fifty-nine studies were included in the final review. Results of the study were classified according to the three phases of the Human Immunodeficiency Virus Prevention Cascade-demand side, supply side, and adherence and retention. The majority of studies ( = 24, 41%) were cross-sectional quantitative surveys and 43 (34%) focused on the demand-side phase of the Human Immunodeficiency Virus Prevention Cascade. Fifty-eight percent of studies either assessed women's pre-exposure prophylaxis knowledge, attitudes, and intentions to use, or assessed perceived barriers and facilitators. Seven studies (12%) tested pre-exposure prophylaxis uptake and adherence among Black cisgender women.

Conclusion: This review found multiple missed opportunities to increase women's demand for pre-exposure prophylaxis and health care provider screening and referral for pre-exposure prophylaxis. Additional studies are needed to effectively assess pre-exposure prophylaxis uptake and adherence among Black cisgender women.

Citing Articles

Black women in HIV research: Intersectionality, positionality and our commitment to build a just research enterprise.

Campbell D, Stockman J Womens Health (Lond). 2024; 20:17455057241305071.

PMID: 39707883 PMC: 11663266. DOI: 10.1177/17455057241305071.

An Examination of Perceptions among Black Women on Their Awareness of and Access to Pre-Exposure Prophylaxis (PrEP).

Hill M, Sapp S, McCants S, Campbell J, Taylor A, Stockman J Int J Environ Res Public Health. 2024; 21(8).

PMID: 39200693 PMC: 11354061. DOI: 10.3390/ijerph21081084.

Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial.

Goddard-Eckrich D, McCrimmon T, Bond K, Chang M, Hunt T, Hall J Addict Sci Clin Pract. 2024; 19(1):55.

PMID: 39039560 PMC: 11264441. DOI: 10.1186/s13722-024-00488-0.

Perceptions of and preferences for PrEP use among African American women and providers in the U.S. South: a qualitative study.

Waldron E, Goodman G, Rivas A, Ott C, Blyler A, McDonald V Psychol Health. 2024; :1-20.

PMID: 38441003 PMC: 11374930. DOI: 10.1080/08870446.2024.2322079.

"Protected Means Armed": Perspectives on Pre-Exposure Prophylaxis (PrEP) Among Women Who Engage in Sex Work and Use Drugs in Kazakhstan.

McCrimmon T, Frye V, Darisheva M, Starbird L, Cordingley O, Terlikbayeva A AIDS Educ Prev. 2023; 35(5):347-361.

PMID: 37843909 PMC: 10901454. DOI: 10.1521/aeap.2023.35.5.347.

References

Willie T, Kershaw T, Campbell J, Alexander K . Intimate Partner Violence and PrEP Acceptability Among Low-Income, Young Black Women: Exploring the Mediating Role of Reproductive Coercion. AIDS Behav. 2017; 21(8):2261-2269. PMC: 5823269. DOI: 10.1007/s10461-017-1767-9. View

Rubtsova A, Wingood G, Dunkle K, Camp C, DiClemente R . Young adult women and correlates of potential adoption of pre-exposure prophylaxis (PrEP): results of a national survey. Curr HIV Res. 2014; 11(7):543-8. PMC: 6905619. DOI: 10.2174/1570162x12666140129104952. View

Chandler R, Hull S, Ross H, Guillaume D, Paul S, Dera N . The pre-exposure prophylaxis (PrEP) consciousness of black college women and the perceived hesitancy of public health institutions to curtail HIV in black women. BMC Public Health. 2020; 20(1):1172. PMC: 7385954. DOI: 10.1186/s12889-020-09248-6. View

Sucharew H, Macaluso M . Progress Notes: Methods for Research Evidence Synthesis: The Scoping Review Approach. J Hosp Med. 2019; 14(7):416-418. DOI: 10.12788/jhm.3248. View

Nydegger L, Dickson-Gomez J, Ko Ko T . Structural and syndemic barriers to PrEP adoption among Black women at high risk for HIV: a qualitative exploration. Cult Health Sex. 2020; 23(5):659-673. PMC: 7529643. DOI: 10.1080/13691058.2020.1720297. View

Flash C, Stone V, Mitty J, Mimiaga M, Hall K, Krakower D . Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis. AIDS Patient Care STDS. 2014; 28(12):635-42. PMC: 4250961. DOI: 10.1089/apc.2014.0003. View

Bond K, Chandler R, Chapman-Lambert C, Jemmott L, Lanier Y, Cao J . Applying a Nursing Perspective to Address the Challenges Experienced by Cisgender Women in the HIV Status Neutral Care Continuum: A Review of the Literature. J Assoc Nurses AIDS Care. 2021; 32(3):283-305. PMC: 10688540. DOI: 10.1097/JNC.0000000000000243. View

LaVeist T, Pollack K, Thorpe Jr R, Fesahazion R, Gaskin D . Place, not race: disparities dissipate in southwest Baltimore when blacks and whites live under similar conditions. Health Aff (Millwood). 2011; 30(10):1880-7. PMC: 6535343. DOI: 10.1377/hlthaff.2011.0640. View

Hill L, Lightfoot A, Riggins L, Golin C . Awareness of and attitudes toward pre-exposure prophylaxis among African American women living in low-income neighborhoods in a Southeastern city. AIDS Care. 2020; 33(2):239-243. PMC: 7686290. DOI: 10.1080/09540121.2020.1769834. View

10.

Calabrese S, Willie T, Galvao R, Tekeste M, Dovidio J, Safon C . Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP. J Acquir Immune Defic Syndr. 2019; 81(4):395-405. PMC: 6594908. DOI: 10.1097/QAI.0000000000002042. View

11.

Adams J, Khan M, Bessey S, Friedman S, McMahon J, Lurie M . Preexposure prophylaxis strategies for African-American women affected by mass incarceration. AIDS. 2020; 35(3):453-462. PMC: 7855567. DOI: 10.1097/QAD.0000000000002749. View

12.

Wingood G, Dunkle K, Camp C, Patel S, Painter J, Rubtsova A . Racial differences and correlates of potential adoption of preexposure prophylaxis: results of a national survey. J Acquir Immune Defic Syndr. 2013; 63 Suppl 1:S95-101. PMC: 3673769. DOI: 10.1097/QAI.0b013e3182920126. View

13.

Kamitani E, Johnson A, Wichser M, Mizuno Y, DeLuca J, Higa D . Mapping the study topics and characteristics of HIV pre-exposure prophylaxis research literature: a protocol for a scoping review. BMJ Open. 2019; 9(5):e024212. PMC: 6537968. DOI: 10.1136/bmjopen-2018-024212. View

14.

Schaefer R, Gregson S, Fearon E, Hensen B, Hallett T, Hargreaves J . HIV prevention cascades: A unifying framework to replicate the successes of treatment cascades. Lancet HIV. 2020; 6(1):e60-e66. PMC: 7025885. DOI: 10.1016/S2352-3018(18)30327-8. View

15.

Gilbert L, Goddard-Eckrich D, Chang M, Hunt T, Wu E, Johnson K . Effectiveness of a Culturally Tailored HIV and Sexually Transmitted Infection Prevention Intervention for Black Women in Community Supervision Programs: A Randomized Clinical Trial. JAMA Netw Open. 2021; 4(4):e215226. PMC: 8035652. DOI: 10.1001/jamanetworkopen.2021.5226. View

16.

Ransome Y, Bogart L, Kawachi I, Kaplan A, Mayer K, Ojikutu B . Area-level HIV risk and socioeconomic factors associated with willingness to use PrEP among Black people in the U.S. South. Ann Epidemiol. 2020; 42:33-41. PMC: 7056502. DOI: 10.1016/j.annepidem.2019.11.002. View

17.

Jackson G, Darlington C, Tieu H, Brawner B, Flores D, Bannon J . Women's views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention. Cult Health Sex. 2021; 24(5):642-656. PMC: 8567214. DOI: 10.1080/13691058.2021.1877824. View

18.

Ojikutu B, Mayer K . HIV Prevention Among Black Women in the US-Time for Multimodal Integrated Strategies. JAMA Netw Open. 2021; 4(4):e215356. DOI: 10.1001/jamanetworkopen.2021.5356. View

19.

Hirschhorn L, Brown R, Friedman E, Greene G, Bender A, Christeller C . Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago. J Acquir Immune Defic Syndr. 2020; 84(5):497-507. PMC: 7378883. DOI: 10.1097/QAI.0000000000002377. View

20.

Hill B, Patel V, Haughton L, Blackstock O . Leveraging Social Media to Explore Black Women's Perspectives on HIV Pre-exposure Prophylaxis. J Assoc Nurses AIDS Care. 2017; 29(1):107-114. PMC: 5768204. DOI: 10.1016/j.jana.2017.06.010. View